Chargement en cours...
Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E
BACKGROUND: Antibody drug conjugate (ADC) showed potent therapeutic efficacy in several types of cancers. The role of autophagy in antitumor effects of ADC remains unclear. METHODS: In this study, the ADC, Rituximab-monomethyl auristatin E (MMAE) with a Valine–Citrulline cleavable linker, was design...
Enregistré dans:
| Publié dans: | Front Immunol |
|---|---|
| Auteurs principaux: | , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6085421/ https://ncbi.nlm.nih.gov/pubmed/30123222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.01799 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|